Oxy210, a Semi-Synthetic Oxysterol, Inhibits Profibrotic Signaling in Cellular Models of Lung and Kidney Fibrosis. | Pharmaceuticals (Basel);16(1)2023 Jan 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Oxy210, a Semi-Synthetic Oxysterol, Inhibits Profibrotic Signaling in Cellular Models of Lung and Kidney Fibrosis.

Wang, Feng; Stappenbeck, Frank; Parhami, Farhad.

Affiliation

Wang F; MAX BioPharma, Inc., 2870 Colorado Avenue, Santa Monica, CA 90404, USA.
Stappenbeck F; MAX BioPharma, Inc., 2870 Colorado Avenue, Santa Monica, CA 90404, USA.
Parhami F; MAX BioPharma, Inc., 2870 Colorado Avenue, Santa Monica, CA 90404, USA.

Pharmaceuticals (Basel) ; 16(1)2023 Jan 12.

Article in En | MEDLINE | ID: mdl-36678611

Key words

TGF-ß signaling; fibrosis; hedgehog (Hh) signaling; oxysterols

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Pharmaceuticals (Basel) Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Pharmaceuticals (Basel) Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza